Loading
Everything OnCo dates to 1962: 8 entries, 5 landmarks, 2 approvals and 1 company founded. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
8 dated entries in OnCo fall in 1962: 5 landmarks, 2 approvals and 1 company founded.
Of those, 8 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Colorectal, breast, gastric and pancreatic adenocarcinoma
Chronic lymphocytic leukaemia, lymphomas and essential thrombocythaemia (historic label). Discontinued
The history entries editors wrote on cancer records: the dated turning points of each disease.
Acute lymphoblastic leukaemia. Pinkel's 'total therapy' at St. Jude: multi-agent induction, cranial irradiation, maintenance; first cures.
Liposarcoma
Early gastric cancer
Early-stage classical Hodgkin lymphoma (stage I to II)
Standard-risk B-cell acute lymphoblastic leukaemia in children
The founded year on company records.
Brussels